Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 16/20 | 0.69 |
| ▸ | CDK2 | P24941 | 16/20 | 0.69 |
| ▸ | CDK7 | P50613 | 11/20 | 0.69 |
| ▸ | CCNH | P51946 | 11/20 | 0.69 |
| ▸ | MNAT1 | P51948 | 9/20 | 0.69 |
| ▸ | CCNK | O75909 | 15/20 | 0.51 |
| ▸ | CDK12 | Q9NYV4 | 15/20 | 0.51 |
| ▸ | CCNT1 | O60563 | 14/20 | 0.51 |
| ▸ | CDK9 | P50750 | 14/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24839814 | 0.82 | CDK7 (1.00) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25604070 | 0.82 | CDK7 (1.00) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL24839809 | 0.82 | CDK7 (1.00) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25580840 | 0.82 | CCNT1 (0.60) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25580517 | 0.81 | CCNT1 (0.74) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25580824 | 0.80 | CDK7 (0.51) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25581304 | 0.79 | CCNT1 (0.55) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25581055 | 0.78 | CCNT1 (0.53) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25580835 | 0.78 | CCNT1 (0.53) | CCNE1CDK2CDK7CCNHMNAT1 | |
| SCHEMBL25581054 | 0.78 | CCNT1 (0.57) | CCNE1CDK2CDK7CCNHMNAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078451-A1 | COMPOUND USED AS CDK7 KINASE INHIBITOR AND USE THEREOF | 浙江同源康医药股份有限公司 | 2023-05-11 | — | — | WO | disclosed |